There’s been an advance in research into pancreatic cancer.

Scientists at Harvard Medical School say they’ve found a new molecular target to attack pancreatic cancer.

They’ve discovered that when the target, called SIRT6, was “turned off,” cancer in human and pig cells progressed and spread uncontrollably.

The hope is that studying SIRT6 could lead to new treatments for the aggressive and often lethal disease.

Pancreatic cancer is among the most deadly forms of the disease, and yet it is among the most underfunded. Our own Libby Znaimer is a pancreatic cancer survivor and a spokesperson for Pancreatic Cancer Canada.

You can read about this latest research, in the journal “Cell“.